Lv4
470 积分 2022-09-04 加入
CCT245718, a dual FLT3/Aurora A inhibitor overcomes D835Y-mediated resistance to FLT3 inhibitors in acute myeloid leukaemia cells
11天前
已完结
Discovery of 5-trifluoromethyl-2-aminopyrimidine derivatives as potent dual inhibitors of FLT3 and CHK1
12天前
已完结
TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax
13天前
已完结
A Dual PI3K/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy
14天前
已完结
Development of a novel albumin-binding prodrug that is cleaved by urokinase-type-plasminogen activator (uPA)
23天前
已完结
Enhancement of CPT-11 antitumor activity by adenovirus-mediated expression of β–glucuronidase in tumors
24天前
已完结
Co‐expression of urokinase, urokinase receptor and PAI‐1 is necessary for optimum invasiveness of cultured lung cancer cells
24天前
已完结
Hybrids from Farnesylthiosalicylic Acid and Hydroxamic Acid as Dual Ras‐Related Signaling and Histone Deacetylase (HDAC) Inhibitors: Design, Synthesis and Biological Evaluation
1个月前
已完结
Engineered platelets as targeted protein degraders and application to breast cancer models
2个月前
已完结
Comparative binding affinity analysis of dual CDK2/FLT3 inhibitors
2个月前
已完结
皖公网安备34019202002308
